Can something still help me if it does not repigment my skin?
Yes. An approach may support sleep, stress, movement, culture, appearance choices, or your sense of control. That does not prove it stops pigment loss or restores color. “Complementary” means it is used with standard care. The word does not show that it changes vitiligo. Evidence Evidence
What is known
- Sources cited, not yet graded
Whole-person care matters because vitiligo can affect daily life and because your goals may include more than changing skin color. Naming the intended outcome helps separate a worthwhile wellbeing practice from an unsupported claim to treat vitiligo.
What is uncertain
- Depends on you
Words such as “natural,” “traditional,” “holistic,” and “clinically tested” do not tell you the quality of evidence. Benefits and harms depend on the exact practice or product and the specific claim being made.
Questions for your clinician or practitioner
What is this approach actually supposed to help me with?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Is the evidence about wellbeing, pigment, or disease activity?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Should I change my diet because I have vitiligo?
Diet and supplements are one of the things people I have heard from ask about most. No specific diet is proven to stop vitiligo or restore color. Nutritious food can support your general health. A diagnosed deficiency or another condition may need its own care. Neither creates one “vitiligo diet” for everyone. Evidence Evidence
What is known
- Sources cited, not yet graded
The current major clinical guidance I read does not present an elimination, detoxification, antioxidant, or other named diet as an established vitiligo treatment. Your nutrition needs and any diagnosed deficiency are separate from claims that a diet can reverse vitiligo.
What is uncertain
- Depends on you
The cited guidance does not establish that a diet changes vitiligo. If your skin changes after a dietary change, timing alone does not prove the diet caused it.
Questions for your clinician or practitioner
Do I need deficiency testing before changing my diet?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What human studies support this diet?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Are vitamins, antioxidants, or herbal supplements worth trying?
These general consumer sources describe variable evidence, product content, interaction, and contamination risks. They do not establish a vitiligo repigmentation benefit. Evidence Evidence Evidence
What is known
- Sources cited, not yet graded
The systematic review I read of nutrition, supplement and herbal adjunctive therapies for vitiligo found those studies heterogeneous and mostly adjunctive. It found them insufficient to establish a universal diet, or a reliable stand-alone vitiligo treatment. US supplement oversight also differs from prescription-drug approval. A product sold without a prescription can vary in content, interact with medicines, cause harm, or complicate other care.
What is uncertain
- Depends on you
A result for one ingredient or research preparation cannot be transferred to another brand or blend. Purity, contamination, undeclared ingredients, interactions, pregnancy considerations, and the reason for a suspected deficiency all require review of the exact product and your health context.
Questions for your clinician or practitioner
Could this product interact with my medicines or conditions?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Was this exact product studied?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Does the benefit claim come from independent evidence or from the seller?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Which supplements have actually been tested in vitiligo?
A short list has. Two reviews between them name ginkgo biloba, Polypodium leucotomos, alpha lipoic acid, vitamins B12, D and E, folic acid, phenylalanine, canthaxanthin and Nigella sativa oil. If a product is not on that list, these reviews found no human trial of it. Evidence Evidence
What is known
- Sources cited, not yet graded
The 2020 supplement review searched two research databases and ended with 26 studies. It called oral ginkgo, oral Polypodium leucotomos with light treatment, and oral phenylalanine with UVA its most promising findings. The 2015 Cochrane review looked at every vitiligo treatment and found 96 trials covering 4,512 people.
What is uncertain
- Depends on you
Promising is not proven. Cochrane found most trials had fewer than 50 people. Only five of its 96 reported all three of the outcomes it cared about. Not one measured whether color was still there two years later. The 2020 review is the friendlier of the two toward supplements, and it did not establish its own commercial independence.
Questions for your clinician or practitioner
Has this been tested in people with vitiligo, or only in a laboratory?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Is ginkgo biloba worth trying?
The case for it rests on one small trial. Cochrane analyzed a trial of 47 people in which oral ginkgo did better than placebo. The 2020 review named it the one supplement it rated promising on its own rather than alongside light. That is where the evidence stops. Evidence Evidence
What is known
- Sources cited, not yet graded
Cochrane put ginkgo through the same analysis as the drug and light treatments it reviewed, and it came out ahead of placebo there. The 2020 review reached the same direction from a different set of studies.
What is uncertain
- Depends on you
Nobody has repeated it at a size that would settle it. Cochrane recorded no trial anywhere that checked whether repigmentation lasted two years. I do not publish an amount to take. A bottle on a shelf is also not automatically the preparation that was studied.
Questions for your clinician or practitioner
What would we expect to see, and by when?
Saving keeps this on your device and needs JavaScript, which is off in this browser.I take ___. Could this interact with it?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Does Polypodium leucotomos make light treatment work better?
The main trial points that way without proving it. Fifty people took the extract or a placebo alongside narrowband UVB. Repigmentation on the head and neck was 44 per cent with the extract and 27 per cent with placebo. The authors report that as P = 0.06, which does not clear the usual bar. Evidence Evidence
What is known
- Sources cited, not yet graded
The trial was randomized, double blind and placebo controlled, which is the strongest design for evidence like this. It ran for about six months. The authors call the head and neck result a clear trend, and the 2020 review lists this pairing among its promising findings.
What is uncertain
- Depends on you
A P value of 0.06 means chance is still a live explanation. The trunk, arms, legs, hands and feet moved by a few points, and none of that was significant. Nobody tested the extract without light treatment. The authors suggest the effect may be larger in lighter skin, which is a suggestion and not a finding.
Questions for your clinician or practitioner
Is this being sold to me as proven?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Would adding this change my light treatment?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
My zinc came back low. Should I take zinc?
Not on this evidence. A 2024 review pooled 41 studies, 3,353 people with vitiligo and 10,638 people without it. Zinc and copper ran lower in the vitiligo group and selenium ran higher. Every one of those studies measured blood, not treatment. Evidence
What is known
- Sources cited, not yet graded
This is the largest thing published on these minerals in vitiligo, and what it found is an association. A tested, diagnosed deficiency is its own health question, and worth raising with your doctor on its own terms.
What is uncertain
- Depends on you
The pooled studies disagreed with each other enormously, which the review reports as very high heterogeneity. None of them tested whether taking zinc or copper changes patches. Low in a group does not mean low in you. Correcting a level is not shown to change vitiligo.
Questions for your clinician or practitioner
Was my level actually tested, and was it outside the normal range?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Is there a reason to treat this apart from my skin?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Does vitamin D bring pigment back?
Nothing published shows that. The study people cite is a 2013 pilot of 16 people with vitiligo. It had no placebo group and nobody was blinded. The authors report repigmentation in 14 of the 16, and a study built that way cannot show what caused it. Evidence Evidence
What is known
- Sources cited, not yet graded
The paper is real and I link to it. The authors say they left out a placebo group on purpose, and that their own design cannot establish the right amount. Twenty-five people took part in total, counting the psoriasis half of the study.
What is uncertain
- Depends on you
An open study with no comparison cannot separate the treatment from time, from the season, or from anything else the group was doing. The 2020 supplement review lists vitamin D among the things studied and leaves it out of its promising findings. Nothing here establishes that vitamin D repigments vitiligo.
Questions for your clinician or practitioner
Has my vitamin D actually been tested?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Is there a reason to treat my level that has nothing to do with my skin?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Nine more answers: high-dose vitamin D, turmeric, a named product’s claims, why searches end in a sale, Ayurveda, homeopathy, acupuncture, and coping without changing your skin color
What about the high-dose vitamin D protocol people post about?
It has a name, the Coimbra protocol, and it comes from the group behind that 2013 pilot. Its own safety paper reports normal average blood results in 319 people. It states its conclusion as safety under supervision by experienced doctors, with a strict diet and a fluid requirement alongside it. I do not publish the amounts, the diet or the tests. Evidence Evidence
What is known
- Sources cited, not yet graded
The concern that paper sets out to answer is high blood calcium and kidney damage. It measured for exactly that, over treatment lasting up to three and a half years, and its average values sat inside the normal range. Knowing the name matters, because searching the name finds the literature and searching for a cure finds a shop.
What is uncertain
- Depends on you
The paper was written by the doctors treating those patients, so it reports on their own practice rather than checking it. It measured laboratory safety and not repigmentation, and vitiligo was not analyzed on its own. Its safety statement is conditional on the supervision it describes. The NIH says separately that very high vitamin D almost always comes from supplements. It lists vomiting, confusion, dehydration and kidney stones among the effects, and kidney failure at the extreme.
Questions for your clinician or practitioner
If I wanted to try this, who would supervise it and what would they watch?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What would make you tell me to stop?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
I keep seeing turmeric. Was it tested?
A cream was. A 2022 pilot randomized 30 people to a turmeric cream or a placebo cream, one on each side of the body, and 24 finished. The treated patches improved more than the placebo ones. Nothing in it tests turmeric swallowed as a capsule or eaten as a spice. Evidence
What is known
- Sources cited, not yet graded
It was double blind and placebo controlled, and each person acted as their own comparison. That design removes a lot of the noise a small study usually carries. It ran for four months, in what the authors describe as mild to moderate vitiligo.
What is uncertain
- Depends on you
Thirty people is a pilot, and the authors call it one. It says nothing about what any product on a shelf contains. It does not support dropping a treatment you are already on, and one small trial is not a reason to expect a result.
Questions for your clinician or practitioner
Is the product you are pointing me to the one that was studied?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Is this instead of my other treatment, or alongside it?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
A site is selling a cream and capsules made for vitiligo. What is it actually claiming?
Read what the seller says, then look for who checked it. Vitilox sells a pigmentation cream and a capsule called Pigmenta+ Advanced. Its footer names Vitilox Australia, and its store selector offers the USA, South Africa, and international. The cream page says it “has been formulated to re-pigment the Vitiligo affected areas of your skin”. The same page says that “The Melanocytes are stimulated into releasing your Melanin”. The cream page also says that because it “only contains natural ingredients there are no known side effects. It is 100% safe.” The capsule page says its blend is “proven to support repigmentation, immune balance, and melanocyte protection”. I read both pages on 21 August 2026. Evidence Evidence
What is known
- Sources cited, not yet graded
Those are strong words and they are checkable ones. “Proven” and “scientifically formulated” both point at research, so the thing to look for is which research. The cream page names no ingredient at all, and neither page cites a study, a trial, a regulator or an author.
What is uncertain
- Depends on you
A page can be rewritten by its owner on any day, so this describes what those two pages said on the date they were read. “No known side effects” and “100% safe” are claims about safety. A product with no published ingredient list is one nobody outside the company can check for an interaction with what you already take.
Questions for your clinician or practitioner
What has been published on this product that I could read?
Saving keeps this on your device and needs JavaScript, which is off in this browser.I take ___. Would this interact with it?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
The capsule lists ginkgo, zinc and copper. Those were tested somewhere - was this product?
Not that I could find. Pigmenta+ Advanced prints ginkgo biloba extract, L-tyrosine, alpha lipoic acid, zinc, copper, vitamin B6, vitamin B12, folic acid, vitamin C, vitamin E, selenium and vitamin D3. Several of those names appear above because somebody ran a trial on them. I searched PubMed and ClinicalTrials.gov for the product name on 21 August 2026. Both returned nothing, so I could not find published trial evidence for this product. Evidence Evidence Evidence
What is known
- Sources cited, not yet graded
A trial tests a specified preparation, at a specified amount, in a described group of people. The ginkgo result above came from a trial of 47 people. A label that prints the same word has not shown it holds the same thing in the same quantity. And no amount is published for any ingredient in this one.
What is uncertain
- Depends on you
I could not find published evidence. That is not the same as evidence that something does not work, and it is not a statement about the seller. It is also possible a company has run a study and not published it, which leaves you in the same position: nothing you can read.
Questions for your clinician or practitioner
Is the product being recommended to me the one that was studied?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Does a bottle that names an ingredient have to contain the amount used in a trial?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Why does everything I find end up selling me something?
Because you are not imagining it, and researchers have written it down. In a 2018 study, 161 people with vitiligo in the UK described searching for information. One of them wrote that “some websites eventually lead into selling some sort of product which is the new ‘best treatment’”. The same participant wrote that “because you are motivated to find some sort of treatment you end up almost believing the hype that they sell”. My own position is that something not yet studied is a reason to stay curious and careful, and never a reason to hand somebody money. If the only place a claim exists is the place the product is sold, that is your answer. Evidence
What is known
- Sources cited, not yet graded
Another participant in the same study described “a lot of commercially orientated websites promoting a variety of herbal cures etc but limited proper evidence based medical guidance”. The authors report two worries running through the answers. People were troubled by the commercial interests of the sites, and by not being able to judge the evidence behind what was on them. Wanting something to work is what makes the pitch land, which is a description of being a patient, not a failing.
What is uncertain
- Depends on you
That study asked people what they thought; it does not measure how many sites sell things or say anything about any named company. A product being sold is not evidence against it either. The question is only ever whether anyone outside the sale has checked it.
Questions for your clinician or practitioner
If I bring you a product I found online, will you tell me what is known about it?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What would count as good evidence for something like this?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What if I am considering Ayurveda or homeopathy?
You deserve a specific answer about the exact product - not a judgment based only on the tradition’s name. I used an Ayurvedic treatment called Switra Niwarane on a patch over my eyelid, consistently, and that spot repigmented. It was pills together with a powder mixed into a paste with lemon juice, applied to the skin and then put in morning or evening sunlight. That is what happened to me, and it is not a regimen for you. I do not publish what I took or for how long. Paste plus sunlight is the same principle as PUVA and other photosensitizer-plus-UV treatments. If you are considering something like it, ask the seller for a heavy-metal test certificate and tell your dermatologist what you are using. Never apply it and then use a phototherapy lamp the same day without your clinician knowing. These general consumer sources do not establish a vitiligo repigmentation benefit, and some products can cause harm. Evidence Evidence
What is known
- Sources cited, not yet graded
NCCIH reports that some Ayurvedic preparations may contain toxic amounts of metals and that high-quality evidence is limited for many claims. It reports no reliable evidence that homeopathy is effective for any health condition.
What is uncertain
- Depends on you
A broad tradition should not be reduced to one product. Limited evidence does not mean another person’s experience is false. Testimonials, long use, or a practitioner’s title still cannot replace evidence for the claim. You also need safety facts for the exact product or procedure.
Questions for your clinician or practitioner
Who verifies the quality of this product or procedure?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What human evidence supports the promised vitiligo result?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Could this interfere with my other care?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
One person’s experience - not medical advice
What repigmented for me, and what I check first
A family member sourced an Ayurvedic product for me: a pill, plus a paste I applied before sitting in the sun. The patch under it repigmented. That does not mean it will work for anyone else.
Before I try something like it, I ask for a heavy-metal test certificate and tell my dermatologist what I am using. I never apply a paste and then use a light box the same day without my clinician knowing.
What about acupuncture?
Reviews of acupuncture for vitiligo do report possible benefit, and they are weak enough that the finding cannot be relied on. An overview of the published systematic reviews found critical methodological and reporting weaknesses and mixed certainty across them. Evidence
What is known
- Sources cited, not yet graded
That overview is the most direct evidence I found on the question, and it is independent of anyone selling the treatment. It sets out what the existing reviews claim and how far their methods support it.
What is uncertain
- Depends on you
It does not establish acupuncture as a standard repigmentation treatment, and it does not validate every related procedure. It is not a recommendation for or against it in your case. Practitioner training, needle safety and cost are separate questions, and a possible benefit reported in weak studies is not a result you should expect.
Questions for your clinician or practitioner
What result is this supposed to produce, and over what period?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What would tell us it is not working?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Can movement, meditation, peer support, or counseling help me cope?
They may support wellbeing, coping, sleep, or stress for some people, even though there is not evidence that they repigment vitiligo. These are optional supports - not proof that stress caused your vitiligo or that coping better will change its course. Evidence Evidence
What is known
- Sources cited, not yet graded
The vitiligo guidelines I read recommend recognizing psychological effects and offering appropriate support. A wellbeing practice can have value on its own terms when it is accessible, acceptable, and safe for you.
What is uncertain
- Depends on you
No single practice fits everyone. If distress is persistent, severe, or connected with your safety, seek qualified mental-health support rather than relying only on a lifestyle practice.
Questions for your clinician or practitioner
What kind of support fits the way vitiligo is affecting my life right now?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Is this for wellbeing or a claim to change pigment?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What if I want to cover my patches sometimes - and not at other times?
That is valid. You can use camouflage sometimes, leave your skin uncovered at other times, pursue medical care, seek emotional support, or combine those choices. None of them proves how you feel about your skin or whether you have “accepted” vitiligo. Evidence Evidence
What is known
- Sources cited, not yet graded
The clinical guidance I read recognizes camouflage and emotional support as parts of care because visible difference can affect daily life. The outcome you want may be confidence or control in one situation, not a biological change in vitiligo.
What is uncertain
- Depends on you
No appearance choice prevents unwanted comments or guarantees confidence, and your preferences may change by day or setting. Your choice does not prescribe how you should feel.
Questions for your clinician or practitioner
What appearance or support options are available if and when I want them?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Can we discuss my goal without assuming concealment or repigmentation?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence and update context
This optional layer shows the evidence boundary I reviewed as of 2026-09-19.
- What this evidence supports
- Whole-person care matters because vitiligo can affect daily life and because your goals may include more than changing skin color. Naming the intended outcome helps separate a worthwhile wellbeing practice from an unsupported claim to treat vitiligo.
- What it does not establish
- Words such as “natural,” “traditional,” “holistic,” and “clinically tested” do not tell you the quality of evidence. Benefits and harms depend on the exact practice or product and the specific claim being made.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Pending clinical review
This statement has a dated source and is waiting for a clinician's sign-off.
Applicability check
Who was studied?
These fields show what the cited evidence reports about the people and body sites behind outcome or safety claims. “Not reported” means the reviewed source omitted the field; “Pending exact source review” means SteadySkin has not made that determination yet.
Diet and supplements are one of the things people I have heard from ask about most. No specific diet is proven to stop vitiligo or restore color. Nutritious food can support your general health. A diagnosed deficiency or another condition may need its own care. Neither creates one “vitiligo diet” for everyone.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- Not reported
- Geography and care setting
- One source is the 2021 UK vitiligo guideline, written for UK clinical care. The other is US patient education from NIAMS. Neither is a study of a diet and neither reports a study population.
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: Neither source is a study of a diet in people with vitiligo. Both are guidance pages that describe treatment types in general terms. Neither names, tests or rules out any one diet. This claim states a gap in the guidance, not a group result.
These general consumer sources describe variable evidence, product content, interaction, and contamination risks. They do not establish a vitiligo repigmentation benefit.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- The cited 2020 systematic review of nutrition, supplement and herbal-based adjunctive therapies for vitiligo covers 26 studies. It does not give a combined participant count across them. The BAD guideline and the NCCIH supplement page are guidance, not studies, and report no sample.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: The review calls its own studies mixed, and most tested a supplement alongside another treatment, not alone. It does not say who paid for them. It does not check any one product for quality or safety. The other two sources are guidance and general consumer pages, not vitiligo safety studies. Together they support that the evidence is thin and that unregulated products carry real risk. None of them gives a rate for that risk.
The case for it rests on one small trial. Cochrane analyzed a trial of 47 people in which oral ginkgo did better than placebo. The 2020 review named it the one supplement it rated promising on its own rather than alongside light. That is where the evidence stops.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- The trial behind this finding enrolled 47 people. Cochrane analyzed it inside its review of 96 vitiligo trials covering 4,512 people overall. The 2020 supplement review names the same finding without giving a separate participant count.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: This is one small trial inside a larger review. No age, skin tone, geography, race or ethnicity is reported for it. It shows ginkgo did better than placebo, and it stops there. No one checked whether the result lasted two years. Forty-seven people is not proof that a bottle on a shelf will do the same.
The main trial points that way without proving it. Fifty people took the extract or a placebo alongside narrowband UVB. Repigmentation on the head and neck was 44 per cent with the extract and 27 per cent with placebo. The authors report that as P = 0.06, which does not clear the usual bar.
- Age range
- Not reported
- Condition subtype
- Vitiligo vulgaris. The trial does not break its result down by a further subtype.
- Severity or extent
- Not reported
- Sample size
- 50 people with vitiligo vulgaris, randomly assigned to oral Polypodium leucotomos extract or placebo, each alongside narrowband UVB, for 25 to 26 weeks.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Head and neck repigmentation was 44% with the extract versus 27% with placebo (P = 0.06). Trunk, arms and legs, and hands and feet moved by 4 to 6 percentage points each, and none of those differences were significant.
What that means for this page: This is one trial of 50 people, not a pooled review. It names no age, skin tone, race or ethnicity for its group. Its head-and-neck result is a trend, not a proven effect. It tested the extract only together with narrowband UVB, never alone. The authors’ idea that lighter skin might respond more is a passing comment, not a checked result.
Nothing published shows that. The study people cite is a 2013 pilot of 16 people with vitiligo. It had no placebo group and nobody was blinded. The authors report repigmentation in 14 of the 16, and a study built that way cannot show what caused it.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- The authors report that 14 of the 16 people with vitiligo had between 25 and 75 per cent repigmentation; the study does not grade baseline severity or extent before treatment.
- Sample size
- 16 people with vitiligo and 9 with psoriasis (25 people total), in an open-label study with no control group and no blinding, over six months.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: This is one pilot of 25 people, 16 of them with vitiligo, with no control group and no blinding. No age, skin tone, geography, race or ethnicity is reported for the group. The authors say they left out a comparison group on purpose. So the study cannot show that vitamin D caused the change it recorded. I do not treat it as evidence you can act on.
It has a name, the Coimbra protocol, and it comes from the group behind that 2013 pilot. Its own safety paper reports normal average blood results in 319 people. It states its conclusion as safety under supervision by experienced doctors, with a strict diet and a fluid requirement alongside it. I do not publish the amounts, the diet or the tests.
- Age range
- Not reported
- Condition subtype
- The safety series covers 319 people with a range of autoimmune conditions; vitiligo is not analyzed as its own group within it. The NIH fact sheet is general consumer guidance and never mentions vitiligo.
- Severity or extent
- Not reported
- Sample size
- 319 people with autoimmune conditions, treated for up to three and a half years, in the safety series. The NIH fact sheet is not a study and reports no sample.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: The safety series checks blood and kidney results in 319 people with autoimmune disease of many kinds. It is not about vitiligo, and it does not measure repigmentation. The doctors who treat these patients wrote it themselves; nobody outside checked their work. Its safety finding only holds under the close supervision, diet and monitoring it describes. The NIH page is general guidance about vitamin D and never mentions vitiligo or this protocol.
A cream was. A 2022 pilot randomized 30 people to a turmeric cream or a placebo cream, one on each side of the body, and 24 finished. The treated patches improved more than the placebo ones. Nothing in it tests turmeric swallowed as a capsule or eaten as a spice.
- Age range
- Not reported
- Condition subtype
- Mild to moderate vitiligo, as described by the authors. The trial does not further subtype by pattern.
- Severity or extent
- Described by the authors as mild to moderate vitiligo; no further severity grading is reported.
- Sample size
- 30 people entered this randomized, double-blind, placebo-controlled pilot; 24 finished. Each person used the turmeric cream on one side of the body and a placebo cream on the other, over four months.
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Applied topically, one side of the body per person against a placebo cream on the other side; the trial does not name which specific body sites were treated.
What that means for this page: This is one pilot of 30 people; 24 finished it. No age, skin tone, geography, race or ethnicity is reported for the group. It tested a cream put on the skin, not turmeric taken by mouth or eaten as a spice. The authors call it a pilot, and thirty people is not enough to prove a benefit beyond the mild-to-moderate patches it describes.
You deserve a specific answer about the exact product - not a judgment based only on the tradition’s name. I used an Ayurvedic treatment called Switra Niwarane on a patch over my eyelid, consistently, and that spot repigmented. It was pills together with a powder mixed into a paste with lemon juice, applied to the skin and then put in morning or evening sunlight. That is what happened to me, and it is not a regimen for you. I do not publish what I took or for how long. Paste plus sunlight is the same principle as PUVA and other photosensitizer-plus-UV treatments. If you are considering something like it, ask the seller for a heavy-metal test certificate and tell your dermatologist what you are using. Never apply it and then use a phototherapy lamp the same day without your clinician knowing. These general consumer sources do not establish a vitiligo repigmentation benefit, and some products can cause harm.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- Not reported
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: Both sources are general US health pages, not vitiligo trials. Neither names a study group, place, skin tone, race, ethnicity or body site. They support that Ayurvedic products can vary in quality and sometimes hold toxic metals. They also support that homeopathy has no proven effect for any condition. That is general safety context, not a vitiligo finding about any one product.
Reviews of acupuncture for vitiligo do report possible benefit, and they are weak enough that the finding cannot be relied on. An overview of the published systematic reviews found critical methodological and reporting weaknesses and mixed certainty across them.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- Not reported
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: This is an overview of published reviews about acupuncture for vitiligo, not one study. It gives no combined group size, age, place, skin tone, race or ethnicity for what those reviews covered. It reports that the reviews it looked at have real problems with their methods and their reporting. That is why I treat any reported benefit as unreliable, not a result to expect.
They may support wellbeing, coping, sleep, or stress for some people, even though there is not evidence that they repigment vitiligo. These are optional supports - not proof that stress caused your vitiligo or that coping better will change its course.
- Age range
- Not reported
- Condition subtype
- Not reported
- Severity or extent
- Not reported
- Sample size
- Not reported
- Geography and care setting
- Not reported
- Skin tone or phototype
- Not reported
- Race
- Not reported
- Ethnicity
- Not reported
- Body sites
- Not reported
What that means for this page: Neither source is a trial of a coping practice. Both are guidance telling clinicians to notice mental-health effects and offer support. Neither names a study group. Neither claims that any one practice repigments vitiligo or has been measured for wellbeing in a defined group.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Journal of Alternative and Complementary Medicine (Shakhbazova A, et al.)Systematic review · Supporting research, tier 3Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that nutrition, supplement and herbal studies are heterogeneous, often adjunctive and insufficient to establish a universal diet or reliable stand-alone vitiligo treatment.
What it does not support
Commercial independence was not established in this review; it does not establish product equivalence, quality, safety, an individual deficiency or a recommendation to use a reviewed ingredient.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Center for Complementary and Integrative HealthPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports general US consumer context that supplement evidence and product content vary and that interactions, contamination and health-condition risks are possible.
What it does not support
It is not vitiligo-specific efficacy evidence, a product-quality verification service or an individual safety determination.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Center for Complementary and Integrative HealthPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that Ayurveda includes varied products and practices, that high-quality evidence is limited for many health claims and that some preparations may contain toxic metals.
What it does not support
It does not evaluate a specific vitiligo product, establish repigmentation benefit or treat an entire tradition as one intervention.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Center for Complementary and Integrative HealthPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that evidence does not establish homeopathy as effective for a specific health condition and that some labeled products can contain active ingredients with side effects or interactions.
What it does not support
It is not a vitiligo trial, an assessment of every individual product or a substitute for product-specific safety review.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Journal of Cosmetic Dermatology (Zhao J, et al.)Systematic review · Supporting research, tier 3Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that published acupuncture reviews report possible benefit but have critical methodological and reporting weaknesses and mixed evidence certainty.
What it does not support
It does not establish acupuncture as a standard repigmentation treatment, validate every related procedure or support an individual recommendation.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Cochrane Database of Systematic Reviews (Whitton ME, et al.)Systematic review · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: Cochrane reviews are prepared to a published method and are not funded by a maker of any reviewed product.
What this source supports
Supports that 96 randomized trials covering 4,512 people had been published on vitiligo treatment when this review closed its search. Among the analyses of more than 75 per cent repigmentation, one trial of 47 people found oral ginkgo biloba better than placebo. Most included trials enrolled fewer than 50 people. Only five of the 96 reported all three of the review’s primary outcomes, which were quality of life, more than 75 per cent repigmentation, and adverse effects. No included trial measured whether repigmentation was still there two years later.
What it does not support
It reviews trials and does not recommend one. It does not establish any supplement as a treatment, set an amount to take, compare brands or preparations, or predict what one person will get. Its search closed in October 2013, so it cannot speak to anything published after that.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Journal of the European Academy of Dermatology and Venereology (Middelkamp-Hup MA, et al.)Randomized trial · Clinical research, tier 2Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The published record read here does not state who funded the trial or what relationship the authors had with the extract’s maker, so independence is recorded as not established rather than assumed.
What this source supports
Supports that 50 people with vitiligo vulgaris were randomly assigned to oral Polypodium leucotomos extract or to placebo, each alongside narrowband UVB, for 25 to 26 weeks. Head and neck repigmentation was 44 per cent with the extract and 27 per cent with placebo, which the authors report as P = 0.06. The differences at the trunk, at the arms and legs, and at the hands and feet were between 4 and 6 percentage points and were not significant. The authors describe the head and neck finding as a clear trend.
What it does not support
A P value of 0.06 does not establish the effect. The trial tested one extract taken together with narrowband UVB, so it says nothing about the extract used on its own, about another brand or preparation, or about a site other than the head and neck. The authors suggest the effect may be larger in lighter skin types, which is a suggestion in their discussion and not a finding. It sets no amount and predicts nothing for one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Scientific Reports (Anam K, et al.)Systematic review · Clinical research, tier 2Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The review pools published blood measurements and has no product to sell; no maker of a supplement is named as a sponsor in the record read here.
What this source supports
Supports that across 41 studies, 3,353 people with vitiligo and 10,638 people without it, average serum zinc and average serum copper were lower in the vitiligo group and average serum selenium was higher. The review reports very high disagreement between the pooled studies, at 95 per cent for zinc and copper and 97 per cent for selenium on its heterogeneity measure. Its stated conclusion is an association.
What it does not support
Every pooled study measured blood levels rather than treatment, so nothing in it tests whether taking zinc, copper or selenium changes vitiligo. A group average does not establish one person’s level, a deficiency, or a reason to supplement. It sets no amount, does not establish which came first, and does not say what should be tested.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Dermato-Endocrinology (Finamor DC, et al.)Observational study · Manufacturer, tier 4Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The paper has no control group, and a later case series records that the approach it reports now carries the surname of its senior author, so independence from an interest in the result is not established.
What this source supports
Supports that 16 people with vitiligo and 9 with psoriasis took a high daily dose of vitamin D for six months in an open-label study with no control group and no blinding. The authors report that 14 of the 16 people with vitiligo had between 25 and 75 per cent repigmentation. Blood levels of vitamin D rose steeply in both groups, and the authors state that no clinical or laboratory sign of toxicity was seen in any of the 25 participants.
What it does not support
With no control group and no blinding, it cannot show what caused the change it reports, and the authors say they avoided a placebo group deliberately. The authors also state that their design precludes establishing an optimal daily amount. It is 25 people over six months, so it establishes neither efficacy nor long-term safety, and I do not publish the amount used, the diet that accompanied it, or the tests that were run.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Nutrients (Amon U, Yaguboglu R, Ennis M, Holick MF, Amon J)Observational study · Manufacturer, tier 4Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The series reports on patients treated by its own authors under the protocol it is assessing, which is a report on their own practice rather than an independent check of it.
What this source supports
Supports that the high-dose vitamin D approach patients meet online is called the Coimbra protocol, and that it is named for the Brazilian group who reported the 2013 pilot. It supports that hypercalcemia and impaired kidney function are the main concerns raised against it. It reports laboratory results for 319 people with a range of autoimmune conditions, treated for up to three and a half years, with mean values inside the normal range for serum calcium, creatinine, estimated GFR, cystatin C, TSH and 24-hour urinary calcium. Its conclusion is stated as safety under appropriate supervision by experienced physicians, alongside a strict low-calcium diet and a daily fluid requirement.
What it does not support
It is a report by the treating clinicians on their own patients, not a controlled trial and not an independent audit. It measures laboratory safety, not repigmentation, and vitiligo is not analysed as its own group. Its safety statement is conditional on the supervision, diet and monitoring it describes, so it does not support anyone following the approach without them. It sets no amount for this site to publish and establishes nothing about what would happen to one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- NIH Office of Dietary SupplementsPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: A US government consumer fact sheet with no product to sell.
What this source supports
Supports that the NIH publishes an upper daily limit for vitamin D for adults, and that going far above it is a real hazard rather than a wasted purchase. It states that very high blood levels of vitamin D can cause nausea, vomiting, muscle weakness, confusion, pain, loss of appetite, dehydration, excessive urination and thirst, and kidney stones, and that extremely high levels can cause kidney failure, irregular heartbeat and death. It states that high levels are almost always caused by taking excessive amounts from supplements.
What it does not support
It is general consumer guidance and never mentions vitiligo. It does not evaluate any vitiligo treatment, assess the Coimbra protocol, establish what any one person’s level is or should be, or say what dose is right for anyone. Its own numbers are reported here as the NIH saying them and are never issued by this site as an instruction.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Journal of Cosmetic Dermatology (Jalalmanesh S, et al.)Randomized trial · Supporting research, tier 3Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The published record read here does not state the funding source or the authors’ interests, so independence is recorded as not established rather than assumed.
What this source supports
Supports that 30 people with vitiligo entered a randomized, double-blind, placebo-controlled pilot of a turmeric cream put on the skin, and that 24 of them finished it. Each person used the turmeric cream on one side of the body and a placebo cream on the other, over four months. The authors report that patch size fell and appearance improved more on the turmeric side than on the placebo side, and they describe the setting as mild to moderate vitiligo.
What it does not support
It is a pilot of 30 people and the authors call it one. It tested a cream put on the skin, not turmeric or curcumin taken by mouth and not a kitchen spice. It does not identify what any product on sale contains, establish a benefit beyond mild to moderate patches, support replacing an existing treatment, or predict a result for one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Vitilox, the company selling the product (vitilox.com)Manufacturer document · Manufacturer, tier 4Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The page is written by the company that sells the product. It names no author, no manufacturer and no regulator, and it cites no study, so nothing on it has been checked by anyone without a commercial interest in the sale.
What this source supports
Supports what this seller says about its own cream, in the seller’s own words. The page states that the cream “has been formulated to re-pigment the Vitiligo affected areas of your skin”. It states that “The Melanocytes are stimulated into releasing your Melanin”. It states that the cream “contains stimulants which are absorbed into the skin causing these cells to re-activate”. It states that the cream “has been described as the most effective cream available for the recovery of your natural skin tone”. It states that because the cream “only contains natural ingredients there are no known side effects. It is 100% safe.” It also supports that the page names no individual ingredient anywhere and cites no study, trial or regulator. The date recorded is the revision date the server reported when the page was read.
What it does not support
None of this is evidence for any of it. A seller describing its own product does not establish that the cream returns pigment, that melanocytes are stimulated, that any ingredient reaches or does anything, that the product is the most effective available, or that it is safe. Customer star ratings on the page are not trial results. The page is changed by its owner at any time, so it records what the seller said on the date read and nothing more.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Vitilox, the company selling the product (vitilox.com)Manufacturer document · Manufacturer, tier 4Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The page is written by the company that sells the supplement. It names no author, no manufacturer and no regulator, and it cites no study behind any of the words it uses, including “scientifically formulated” and “proven”.
What this source supports
Supports what this seller says about its own capsule, and the ingredient names it prints. The page states that the product is “scientifically formulated to support Melanocyte Health and stimulate Natural Melanin production”. It states that the blend targets “the root causes of pigment loss”. It states that the product adds “a powerful, targeted blend of ingredients proven to support repigmentation, immune balance, and melanocyte protection”. It lists the contents as ginkgo biloba extract, L-tyrosine, alpha lipoic acid, zinc, copper, vitamin B6, vitamin B12, folic acid, vitamin C, vitamin E, selenium and vitamin D3. The date recorded is the revision date the server reported when the page was read.
What it does not support
It establishes nothing about what the product does. It cites no trial of the product, names no study behind “proven” or “scientifically formulated”, gives no amount of any ingredient, and reports no result in anyone. Printing the name of a substance that has been studied elsewhere is not evidence that this product was studied or that it contains what a study used. The page is changed by its owner at any time.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- BMJ Open (Teasdale E, Muller I, Abdullah Sani A, Thomas KS, Stuart B, Santer M)Observational study · Supporting research, tier 3Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: It is peer-reviewed academic research. The paper states that it received no specific grant from any funding agency in the public, commercial or not-for-profit sectors, and declares no competing interests. Nobody involved sells a vitiligo product.
What this source supports
Supports that people with vitiligo report running into product selling when they search for information, in their own written words. 161 members of the UK Vitiligo Society answered free-text questions in 2016. One wrote of “a lot of commercially orientated websites promoting a variety of herbal cures etc but limited proper evidence based medical guidance”. Another wrote that “some websites eventually lead into selling some sort of product which is the new ‘best treatment’” and that “because you are motivated to find some sort of treatment you end up almost believing the hype that they sell”. The authors report concern about the commercial interests of websites and about being able to judge the evidence behind products and procedures.
What it does not support
It is a qualitative study of what people said, not a measurement of how common anything is. Its participants were self-selected members of one UK patient organisation, so it does not describe vitiligo generally or any other country. It evaluates no named product and no seller, judges no company’s intent, and establishes nothing about whether any product works.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- British Journal of Dermatology (Eleftheriadou V, et al.)Guideline · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports the clinical history and assessment domains, evaluation of associated autoimmune conditions, its recommendation for thyroid function and antithyroid antibody screening, current classification context, treatment-option map, psychosocial assessment, medical photography and the limits of pediatric evidence. Its classification table defines mucosal vitiligo as the oral or genital mucosae. One mucosal site alone is filed as undetermined or unclassified. Its differential diagnosis table lists genital or extragenital lichen sclerosus among the conditions that can be mistaken for vitiligo. That table also lists eczema, psoriasis, lichen planus, pityriasis alba and piebaldism. It calls autoimmunity a contributor to the pathogenesis of vitiligo. It reports an earlier review finding a possible negative impact on intimacy and sexual functioning. It tells clinicians to discuss the psychosocial impact of living with the condition. R28 offers a skin camouflage visit to people who want one. R10 to R14 name potent or very potent topical steroids as the first choice, with a topical calcineurin-inhibitor cream as an option for the face. These are different creams with different proof behind them. R20 names narrowband UVB as the first light option. It says the skin often does better on the face and trunk than on hands and feet. It says there is not enough proof to use any one current pill alone for vitiligo that is not changing. R25 and Table 2 keep cell grafting for vitiligo that is not changing and did not respond to other care. They also say a doctor cannot always tell if the vitiligo has truly stopped changing.
What it does not support
It was designed for UK care and reviewed literature through May 2019; it does not establish a universal testing plan, prescribe an individual plan, or establish current US labeling or coverage. Its differential diagnosis table is a list, not a method a reader can apply to their own skin. It does not say how to tell any two of those conditions apart. It gives no figure for how often vitiligo affects genital skin.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports a patient-facing description of clinician diagnosis using history and examination, possible use of a Wood lamp and selected tests, broad treatment categories, variable response and whole-person support.
What it does not support
It is educational context, not primary efficacy evidence, an online diagnostic method or a universal testing checklist.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.